Close Menu

NEW YORK – Natera said on Monday that Medicare Administrative Contractor Noridian has issued positive coverage for its Prospera donor-derived cell-free DNA organ transplant test.

In addition, Noridian is developing a generic policy for dd-cfDNA tests that will include several commercially available tests. Prospera's coverage will be under this new policy in the future, Natera said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.